Consolidated Statement of Changes in Stockholders' Equity/(Deficit) - USD ($)	Preferred Stock [Member] Series D Convertible Preferred Stock [Member]	Common stock No Par Value [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019			$ 3,806	$ 36,848,063	$ (39,184,699)	$ (2,332,830)
Beginning balance, shares at Dec. 31, 2019			27,785,366
Net loss					(9,487,824)	(9,487,824)
Private placement of common shares			$ 198	1,979,802		1,980,000
Private placement of common shares, shares			767,941
Modification of the terms of 4,188,315 MyMD stock options				2,009,145		2,009,145
Stock-based compensation for borrowings				1,719,477		1,719,477
Stock-based compensation				855,000		855,000
Ending balance, value at Dec. 31, 2020			$ 4,004	43,411,487	(48,672,523)	(5,257,032)
Ending balance, shares at Dec. 31, 2020			28,553,307
Net loss					(29,889,045)	(29,889,045)
Reverse merger with Akers Biosciences Inc effective April 16, 2021	$ 144,524	42,332,834				42,477,358
Reverse merger with Akers Biosciences Inc effective April 16, 2021, shares	72,992		8,335,627
Issuance of post-merger MyMD Pharmaceutical Inc common shares at an exchange ratio of 0.7718 per pre-merger MyMD common share		43,415,491	$ (4,004)	(43,411,487)
Modification of the terms of 4,188,315 pre-merger MyMD stock options per the terms of the merger agreement		15,036,051				15,036,051
Exercise of per-merger MyMD stock options
Exercise of per-merger MyMD stock options, shares			11,576			11,576
Exercise of prepaid equity forward contracts for common stock
Exercise of prepaid equity forward contracts for common stock, shares			466,716
Stock based compensation for services		90,002				90,002
Stock based compensation for services, shares			16,826
Exercise of warrants for common stock		1,189,840				1,189,840
Exercise of warrants for common stock, shares			289,058
Ending balance, value at Dec. 31, 2021	$ 144,524	$ 102,064,218			$ (78,561,568)	$ 23,647,174
Ending balance, shares at Dec. 31, 2021	72,992		37,673,110